Determination of meloxicam in bulk and pharmaceutical formulations.
暂无分享,去创建一个
N H Zawilla | M Abdul-Azim Mohammad | N M El kousy | S M El-Moghazy Aly | N. H. Zawilla | M. Abdul-Azim Mohammad | N. M. El kousy | S. M. el-Moghazy Aly | N. El Kousy
[1] J. Joseph-Charles,et al. Determination of meloxicam in tablet formulations by ultraviolet spectrophotometry and high-performance liquid chromatography , 1999 .
[2] R. Bhardwaj,et al. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[3] J. van Ryn,et al. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer , 1998, Inflammation Research.
[4] D. C. Dashfield. HER MAJESTY'S STATIONERY OFFICE , 1954 .
[5] C. Cywin,et al. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity. , 1997, Journal of medicinal chemistry.
[6] L. Bebawy. Stability-Indicating Method for the Determination of Meloxicam and Tetracaine Hydrochloride in the Presence of their Degradation Products , 1998 .
[7] J. Joseph-Charles,et al. SIMULTANEOUS HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY OXICAMS IN PHARMACEUTICAL PREPARATIONS , 1999 .
[8] M. Abdelsalam,et al. Spectrophotometric Determination of Some Tranquillizers and Antidepressants Using 2,3-Dichloro 5,6-Dicyano-p-Benzoquinone , 1985 .